Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/18173
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStevens, Hannah-
dc.contributor.authorRaj, Kavita-
dc.contributor.authorAshby, Michael-
dc.contributor.authorGrigg, Andrew P-
dc.date2017-10-31-
dc.date.accessioned2018-08-08T02:11:11Z-
dc.date.available2018-08-08T02:11:11Z-
dc.date.issued2018-07-
dc.identifier.citationLeukemia & lymphoma 2018; 59(7): 1750-1752-
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/18173-
dc.language.isoeng-
dc.titleAllogeneic stem cell transplantation as a risk factor for recurrent melanoma.-
dc.typeJournal Article-
dc.identifier.journaltitleLeukemia & lymphoma-
dc.identifier.affiliationDepartment of Clinical Haematology, Austin Health, Heidelberg, Victoria, Australia-
dc.identifier.affiliationDepartment of Haematology, King's College Hospital, London, UK-
dc.identifier.doi10.1080/10428194.2017.1393670-
dc.identifier.pubmedid29087220-
dc.type.austinJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptClinical Haematology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

4
checked on Feb 5, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.